[go: up one dir, main page]

BRPI0922981A8 - método para o controle do peso molecular polissacarídeo para o sorotipo 19a de streptococcus pneumoniae - Google Patents

método para o controle do peso molecular polissacarídeo para o sorotipo 19a de streptococcus pneumoniae Download PDF

Info

Publication number
BRPI0922981A8
BRPI0922981A8 BRPI0922981A BRPI0922981A8 BR PI0922981 A8 BRPI0922981 A8 BR PI0922981A8 BR PI0922981 A BRPI0922981 A BR PI0922981A BR PI0922981 A8 BRPI0922981 A8 BR PI0922981A8
Authority
BR
Brazil
Prior art keywords
streptococcus pneumoniae
fermentation culture
molecular weight
weight control
addition
Prior art date
Application number
Other languages
English (en)
Inventor
Heather Crinean Jean
Original Assignee
Wyeth Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth Llc filed Critical Wyeth Llc
Publication of BRPI0922981A2 publication Critical patent/BRPI0922981A2/pt
Publication of BRPI0922981A8 publication Critical patent/BRPI0922981A8/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20Bacteria; Culture media therefor
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00Preparation of compounds containing saccharide radicals
    • C12P19/04Polysaccharides, i.e. compounds containing more than five saccharide radicals attached to each other by glycosidic bonds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/04Immunostimulants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)

Abstract

"método para o controle do peso molecular de polissacarídeo para o sorotipo 19a de streptococcus pneumoniae". a presente invenção refere-se a métodos melhorados para a produção de uma solução contendo polissacarídeos capsulares 19a de streptococcus pneumoniae isolado de alto peso molecular. em certos métodos, uma cultura de fermentação de células bacterianas de streptococcus pneumoniae que produzem polissacarídeos capsulares para o sorotipo 19a é fermentada durante menos do que 6 horas antes das células bacterianas serem submetidas à lise e os polissacarídeos capsulares são colhidos. em outros métodos, co2 é fornecido à cultura de fermentação. o fornecimento de co2 à cultura de fermentação inclui a adição de íons de bicarbonato na cultura de fermentação, a adição de íons de carbonato na cultura de fermentação, a adição de misturas de íons de bicarbonato e carbonato na cultura de fermentação, e sobreposição da cultura de fermentação com co2.
BRPI0922981-7 2008-12-18 2009-12-17 método para o controle do peso molecular polissacarídeo para o sorotipo 19a de streptococcus pneumoniae BRPI0922981A8 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US13856308P 2008-12-18 2008-12-18
PCT/US2009/068429 WO2010080486A2 (en) 2008-12-18 2009-12-17 Method for controlling streptococcus pneumoniae serotype 19a polysaccharide molecular weight

Publications (2)

Publication Number Publication Date
BRPI0922981A2 BRPI0922981A2 (pt) 2015-08-25
BRPI0922981A8 true BRPI0922981A8 (pt) 2019-11-26

Family

ID=42266457

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0922981-7 BRPI0922981A8 (pt) 2008-12-18 2009-12-17 método para o controle do peso molecular polissacarídeo para o sorotipo 19a de streptococcus pneumoniae

Country Status (19)

Country Link
US (1) US8795689B2 (pt)
EP (1) EP2379734B1 (pt)
JP (1) JP5843612B2 (pt)
KR (2) KR20110091546A (pt)
CN (1) CN102257155B (pt)
AU (1) AU2009335826B2 (pt)
BR (1) BRPI0922981A8 (pt)
CA (1) CA2743710C (pt)
DK (1) DK2379734T3 (pt)
ES (1) ES2666698T3 (pt)
HK (1) HK1163750A1 (pt)
HU (1) HUE037465T2 (pt)
IL (1) IL213169A (pt)
MX (1) MX2011006432A (pt)
PL (1) PL2379734T3 (pt)
PT (1) PT2379734T (pt)
RU (1) RU2511404C2 (pt)
SI (1) SI2379734T1 (pt)
WO (1) WO2010080486A2 (pt)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI2385981T1 (sl) * 2008-12-18 2019-11-29 Wyeth Llc Postopek za nadzorovanje molekulske mase polisaharida streptococcus pneumoniae z uporabo ogljika
DK2424562T3 (en) 2009-04-30 2015-12-07 Coley Pharm Group Inc Pneumococcal vaccine and uses thereof
US9249439B2 (en) 2011-12-15 2016-02-02 Serum Institute Of India Ltd. Process of cultivating bacteria for yield improvement of capsular polyoses
BR112015005081B1 (pt) 2012-09-07 2021-10-26 Sk Bioscience Co., Ltd. Método para produzir um polissacarídeo capsular tendo um sorotipo de pneumococo
US11951165B2 (en) 2016-12-30 2024-04-09 Vaxcyte, Inc. Conjugated vaccine carrier proteins
MX2019007910A (es) 2016-12-30 2019-12-05 Sutrovax Inc Conjugados de polipeptido-antigeno con aminoacidos no naturales.
CN110225764A (zh) 2017-01-31 2019-09-10 默沙东公司 制备多糖-蛋白缀合物的方法
US11090374B2 (en) 2017-02-24 2021-08-17 Merck Sharp & Dohme Corp. Enhancing immunogenicity of Streptococcus pneumoniae polysaccharide-protein conjugates
KR102634811B1 (ko) 2017-06-10 2024-02-06 인벤트프라이즈 인크. 면역원성과 항원항체 결합성이 개선된 2가 또는 다가 접합체 다당류를 가진 다가 접합체 백신
US10729763B2 (en) 2017-06-10 2020-08-04 Inventprise, Llc Mixtures of polysaccharide-protein pegylated compounds
CN111065387B (zh) 2017-09-07 2023-08-25 默沙东有限责任公司 肺炎球菌多糖及其在免疫原性多糖-载体蛋白缀合物中的用途
CA3074703A1 (en) 2017-09-07 2019-03-14 Merck Sharp & Dohme Corp. Pneumococcal polysaccharides and their use in immunogenic polysaccharide-carrier protein conjugates
EP3720483A2 (en) 2017-12-06 2020-10-14 Merck Sharp&Dohme Corp. Compositions comprising streptococcus pneumoniae polysaccharide-protein conjugates and methods of use thereof
KR20190121713A (ko) * 2018-04-18 2019-10-28 에스케이바이오사이언스(주) 스트렙토코커스 뉴모니애 협막 다당류 및 그의 면역원성 접합체
CN112074293A (zh) 2018-04-30 2020-12-11 默沙东公司 生产肺炎链球菌荚膜多糖载体蛋白缀合物的方法
JP7489324B2 (ja) 2018-04-30 2024-05-23 メルク・シャープ・アンド・ドーム・エルエルシー リオスフィアから肺炎連鎖球菌莢膜多糖類キャリアタンパク質コンジュゲートを生産する方法
JP7397000B2 (ja) 2018-04-30 2023-12-12 メルク・シャープ・アンド・ドーム・エルエルシー 凍結乾燥変異ジフテリア毒素のジメチルスルホキシド中均一溶液を提供する方法
US20220296695A1 (en) 2018-12-19 2022-09-22 Merck Sharp & Dohme Corp. Compositions comprising streptococcus pneumoniae polysaccharide-protein conjugates and methods of use thereof
US12053515B2 (en) 2020-08-10 2024-08-06 Inventprise, Inc. Multivalent pneumococcal glycoconjugate vaccines containing emerging serotype 24F

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1115210A (en) 1977-11-28 1981-12-29 Dennis J. Carlo Pneumococcal vaccine
US4221906A (en) 1979-03-19 1980-09-09 American Cyanamid Company Stabilization of pneumococcal polysaccharides
US4242501A (en) 1979-08-08 1980-12-30 American Cyanamid Company Purification of pneumococcal capsular polysaccharides
FR2495939B1 (fr) 1980-12-11 1985-10-11 Merieux Inst Procede de purification de polyosides de streptococcus pneumoniae et vaccin a base de polyosides ainsi purifies
BE889979A (fr) 1981-08-14 1982-02-15 Smith Kline Rit Procede de preparation de polysaccharides bacteriens capsulaires antigeniques purifies, produits obtenus et leur utilisation
US4686102A (en) 1984-04-12 1987-08-11 American Cyanamid Company Multivalent pneumococcal vaccine and preparation thereof
CA2059693C (en) * 1991-01-28 2003-08-19 Peter J. Kniskern Polysaccharide antigens from streptococcus pneumoniae
CA2059692C (en) 1991-01-28 2004-11-16 Peter J. Kniskern Pneumoccoccal polysaccharide conjugate vaccine
US5314822A (en) * 1992-10-15 1994-05-24 Merck & Co., Inc. Method of clonal growth of Streptococcus pneumoniae
US5714354A (en) 1995-06-06 1998-02-03 American Home Products Corporation Alcohol-free pneumococcal polysaccharide purification process
US6146902A (en) 1998-12-29 2000-11-14 Aventis Pasteur, Inc. Purification of polysaccharide-protein conjugate vaccines by ultrafiltration with ammonium sulfate solutions
DK1268844T3 (da) * 2000-03-16 2009-11-16 Philadelphia Children Hospital Modulering af fremstilling af pneumococcus kapselformigt polysaccharid
US6743610B2 (en) 2001-03-30 2004-06-01 The University Of Chicago Method to produce succinic acid from raw hydrolysates
ITTS20010013A1 (it) 2001-06-04 2002-12-04 Ct Ricerche Poly Tec H A R L S Nuovi derivati di ialuronano.
SI1664319T1 (sl) 2003-09-11 2010-06-30 An Vws De Staat Der Nederlande Postopek za pripravo kapsularnega polisaharida zauporabo v konjugatnih vakcinah
KR102220506B1 (ko) 2005-04-08 2021-03-02 와이어쓰 엘엘씨 다가 폐렴구균 다당류-단백질 접합체 조성물
US7709001B2 (en) 2005-04-08 2010-05-04 Wyeth Llc Multivalent pneumococcal polysaccharide-protein conjugate composition
US20070184072A1 (en) 2005-04-08 2007-08-09 Wyeth Multivalent pneumococcal polysaccharide-protein conjugate composition
DK3466982T3 (da) * 2005-04-08 2020-08-03 Wyeth Llc Separation af forurenende kontaminanter fra streptococcus pneumoniae-polysaccharid ved ph-manipulation
US7955605B2 (en) 2005-04-08 2011-06-07 Wyeth Llc Multivalent pneumococcal polysaccharide-protein conjugate composition
GB0522303D0 (en) * 2005-11-01 2005-12-07 Chiron Srl Culture method
RU2460539C2 (ru) 2006-10-10 2012-09-10 Вайет СПОСОБ ОЧИСТКИ ПОЛИСАХАРИДОВ Streptococcus pneumoniae 3 ТИПА (ВАРИАНТЫ)
US7860500B2 (en) * 2006-10-27 2010-12-28 Motorola, Inc. Method and apparatus for determining appropriate channels for communication
CL2008000831A1 (es) * 2007-03-23 2008-07-04 Wyeth Corp Procesos para extraer exceso de proteina soluble e impurezas a partir de lisados celulares de serotipos de streptococcus pneumoniae utilizados en la produccion de polisacaridos neumococales.
SI2385981T1 (sl) 2008-12-18 2019-11-29 Wyeth Llc Postopek za nadzorovanje molekulske mase polisaharida streptococcus pneumoniae z uporabo ogljika

Also Published As

Publication number Publication date
DK2379734T3 (en) 2018-04-23
WO2010080486A2 (en) 2010-07-15
KR20110091546A (ko) 2011-08-11
WO2010080486A3 (en) 2010-11-04
KR101593770B1 (ko) 2016-02-15
US8795689B2 (en) 2014-08-05
KR20130136011A (ko) 2013-12-11
US20100158953A1 (en) 2010-06-24
CA2743710C (en) 2017-01-24
SI2379734T1 (en) 2018-05-31
IL213169A (en) 2015-02-26
JP2012512660A (ja) 2012-06-07
RU2011128564A (ru) 2013-01-27
PT2379734T (pt) 2018-04-27
EP2379734A2 (en) 2011-10-26
MX2011006432A (es) 2011-09-29
CA2743710A1 (en) 2010-07-15
EP2379734B1 (en) 2018-03-21
HK1163750A1 (zh) 2012-09-14
JP5843612B2 (ja) 2016-01-13
RU2511404C2 (ru) 2014-04-10
IL213169A0 (en) 2011-07-31
HUE037465T2 (hu) 2018-09-28
AU2009335826A1 (en) 2010-07-15
CN102257155A (zh) 2011-11-23
BRPI0922981A2 (pt) 2015-08-25
PL2379734T3 (pl) 2018-08-31
CN102257155B (zh) 2016-03-02
AU2009335826B2 (en) 2013-10-31
ES2666698T3 (es) 2018-05-07

Similar Documents

Publication Publication Date Title
BRPI0922981A8 (pt) método para o controle do peso molecular polissacarídeo para o sorotipo 19a de streptococcus pneumoniae
Bunesova et al. Mucin cross-feeding of infant bifidobacteria and Eubacterium hallii
Chow et al. Using recombinant cyanobacterium (Synechococcus elongatus) with increased carbohydrate productivity as feedstock for bioethanol production via separate hydrolysis and fermentation process
BR112013023715A2 (pt) "polipeptídeo, polinucleotídeo, vetor, célula hospedeira, e composição para uso em hidrólise de biomassa, bem como métodos para hidrolisar material de biomassa celulósica e para produzir composição de mistura de cultura ou caldo de fermentação"
MX346071B (es) Método para controlar el peso molecular del polisacárido de streptococcus pneumoniae utilizando dióxido de carbono.
Zhilina et al. Fuchsiella alkaliacetigena gen. nov., sp. nov., an alkaliphilic, lithoautotrophic homoacetogen from a soda lake
BR112021017091A2 (pt) Célula microbiana geneticamente modificada, uso da referida célula, método para a produção fermentativa de um carboidrato de interesse e uso do mesmo
BR112012011711A2 (pt) Variantes de beta-glucosidase 1 (bgl1) com propriedades otimizadas, seu método de produção, composição, ácido nucleico, vetor de expressão, célula hospedeira, bem como método de conversão de biomassa em açúcares
BRPI0619325B8 (pt) célula hospedeira microbiana recombinante e método para produção de isobutanol
BR112013009583A2 (pt) ácido nucleico, vetor, célula hospedeira, métodos de preparação de uma linhagem bacteriana variante de tipificação, de marcação, de geração e de controle de populações bacterianas, linhagem e célula bacteriana variante, kit, uso de um ácido nucleico, cultivo celular, produto, processo de preparação de produtos, mutantes de fago e mutante de escape de fago
Williams et al. Cold adaptation of the Antarctic haloarchaea Halohasta litchfieldiae and Halorubrum lacusprofundi
BR112014006244A2 (pt) microrganismos e métodos para produzir alcenos
NZ593794A (en) Bacterial vaccines with cell wall-associated ceramide-like glycolipids and uses thereof
van Gelder et al. Ercella succinigenes gen. nov., sp. nov., an anaerobic succinate-producing bacterium
BRPI0714212B8 (pt) método de produzir uma glicoproteína em uma cultura celular
NZ603546A (en) Yeast production culture for the production of butanol
BR112014032544A2 (pt) método para produzir iduronato-2-sulfatase recombinante
BR112013020217A2 (pt) método e biorreator para o cultivo de micro-organismos
CN102181470B (zh) 提高链霉菌抗生素产量的方法及其质粒
AR092630A1 (es) Metodos y composiciones para prevenir la incorporacion erronea de norleucina en proteinas
BR112014019166A2 (pt) promotores para expressão aumentada de proteína em meningococos
Ahring et al. Methanogenesis from acetate: physiology of a thermophilic, acetate-utilizing methanogenic bacterium
BR112013028403A2 (pt) método para identificação de alvos para antibióticos por sequencimento complementado
BR112013028406B8 (pt) Método para identificar alvos de antibióticos
BRPI1008762B8 (pt) métodos para seleção de células de mamífero expressando uma proteína heteróloga, para produzir um produto de interesse e uso de um meio de cultura seletivo

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]

Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS.

B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]
B12B Appeal against refusal [chapter 12.2 patent gazette]
B25G Requested change of headquarter approved

Owner name: WYETH LLC (US)